Study links annual haze with increased hospitalizations for respiratory problems

For more than a decade, Southeast Asia has faced annual haze due to a combination of human activity, natural fires, and climatic factors. A new study published in Respirology reveals that the annual haze is associated with increased hospital admissions for respiratory problems.

Respiratory admissions at Universiti Kebangsaan Malaysia Medical Centre were significantly different between haze and non-haze periods in 2014 and 2015, with 27.6 cases per week during the haze periods versus 15.7 cases per week during the non-haze periods. A total of 4% versus 2% of patients were admitted to the intensive care unit in the haze and the non-haze groups, respectively.

"Green measures including tax breaks, expanding the use of public transportation, energy efficient vehicles and alternative energy sourcing such as solar should be encouraged to control overall air pollution," the authors wrote. "The annual haze which is aggravated by human activities is an important modifiable determinant of local lung health, which in turn will affect the policies by the health ministry to improve health care services in Malaysia."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Recruitment underway for a clinical trial testing new vaccine against respiratory viruses